@misc{indiciae5219ca2b211b,
  title = {Efficacy and safety of ferric citrate tablets in Chinese patients with hyperphosphatemia undergoing maintenance hemodialysis: a multicenter, randomized, open-label, active-controlled, phase III trial.},
  author = {Jie Ma and Bicheng Liu and Jialiang Pang and Pei Wang and Ying Li and Caili Wang and Donghui Zheng and Xiaoping Wang and Xiumei Hu and Jianrong Zhao and Xinzhou Zhang and Changchun Cao and Zunsong Wang and Li Xing and Suhua Li and Hong Cheng and Jian Huang and Yi Yang and Xiaolan Chen and Kun Ye and Tiekun Yan and Lianhua Chen and Guojuan Zhang and Feng Zheng and Siyuan Teng and Qing Zhu and Hong Liu and Xuemei Li},
  year = {2026},
  doi = {10.1080/0886022x.2025.2534019},
  url = {https://pubmed.ncbi.nlm.nih.gov/42675918/},
  note = {Source identifier: 42675918}
}